Follow-The-Filings

Security

Anixa Biosciences Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

5 owners 2 exits max 0.0% (Vanguard Group Inc.)

owners 5
max % 0.0%
tracked value $5M
qoq A 3 R 2 E 2

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 1,459,574 $5M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 173,179 $447 hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 61,173 $158 hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce 0.00 pp 17,276 $45 hist
Ancora Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 1,275 $3 hist
Ken Griffin - Citadel Advisors LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 29,692 $93 hist
Israel Englander - Millennium Management LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 12,177 $38 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $210,000
Gross profit
Gross margin
Net income -$9.81M -$12.55M -$10.93M
Net margin * -4671.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $25.36M $21.36M $15.89M
Total non-current assets * $166,000 $229,000 $193,000
Total assets $25.52M $21.59M $16.08M
Total current liabilities $2.03M $2.5M $1.97M
Total non-current liabilities * $123,000 $203,000 $163,000
Total equity $24.34M $20M $15.16M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$6.21M -$7.34M -$7.17M
Cash from investing -$5.6M $4.28M $4.87M
Cash from financing $366,000 $3.42M $2.28M
Net change in cash -$11.44M $356,000 -$27,000

ownership over time

filing count by report period · click a bar for that quarter’s holders